Multiple System Atrophy

Cognitive Impairment in Multi-System Atrophy: Is It Time to Update Diagnostic Criteria?

Cognitive Impairment in Multi-System Atrophy: Is It Time to Update Diagnostic Criteria?

By

Although evidence of cognitive impairment in MSA is admittedly more limited than in Parkinson disease, it is now substantial enough to address modification of diagnostic criteria to include the potential for cognitive impairment at any stage of the disease.

Atypical Parkinsonian Disorders: Reviewing the Complex Web of Proteinopathies

Atypical Parkinsonian Disorders: Reviewing the Complex Web of Proteinopathies

By

While parkinsonian disorders share a common mechanism of protein aggregation, manifestations are quite varied.

Risk for Death Significantly Increased in Patients With Synucleinopathies

Risk for Death Significantly Increased in Patients With Synucleinopathies

By

Patients with multiple system atrophy with parkinsonism face the greatest risk for death among synucleinopathies.

Sign Up for Free e-newsletters

CME Focus